Galician research is once again at the forefront of science. The work led by researcher Helena Rouco-Taboada has been awarded an honorable mention in the J.F. Suárez Freire Prize, granted by the Royal Academy of Pharmacy of Galicia (RAFG).
The project stands out for the development of intra-articular hydrogels specifically designed for the treatment of osteoarthritis, a chronic condition that affects the mobility of millions of people. This solution aims not only to alleviate symptoms but also to reduce joint damage more efficiently and lastingly than current treatments.
A success of multidisciplinary collaboration
This recognition underscores the importance of networking among several prestigious institutions in Galicia:
- iMATUS (Materials Institute of the University of Santiago).
- IDIS (Health Research Institute of Santiago).
- The Faculty of Veterinary Medicine of the University of Santiago de Compostela.
- The support of the CRS-SPLC (Controlled Release Society – Spain and Portugal Local Chapter).
Research Milestones
The award-winning proposal focuses on the application of advanced biomaterials that allow for the controlled release of drugs directly into the joint. According to recent statements by the researchers, these hydrogels represent a significant leap forward by minimizing the impact of joint wear and tear and improving patients’ quality of life.
This award reaffirms the commitment of the Royal Academy of Pharmacy of Galicia to research excellence, recognizing work that has a direct impact on public health and the Galician pharmaceutical heritage.